Virology - vaccines, antivirals, viral evolution Flashcards

1
Q

What’s in a vaccine, broadly speaking? (5)

A

water
preservatives & stabilisers
active ingrediant (antigen)
adjuvant
residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Active vs passive immunization

A

active = administer antigen or parts
passive = administer immune response products like antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

attenuated and inactivated vaccines.

A

Vaccine attenuation means the alteration of a virus to decrease or inhibit its virulence whilst remaining replication competent.

Inactivated vaccines cannot infect cells and replicate, but can still trigger an immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Modern vaccines are based on 4 molecular techniques

A

I. Recombinant vaccines
II. Genetic attenuation
III. Vector vaccines
IV. Other (e.g. mRNA vaccines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the main difference between mRNA and vector vaccine

A

The mRNA vaccine contains messenger RNA.
The vector vaccine contains viral genome that encodes spike protein for the target pathogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical trial phase I involves?

A

tests safety of vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical trial phase II involves?

A

tests immunogenicity of vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

clinical trial phase III involves?

A

tests efficacy of vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

clinical trial phase IV involves?

A

extended clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Efficacy vs effectiveness

A

vaccine efficacy refers to how the vaccine performs in indeal conditions - controlled clinical trials.

vaccine effectiveness refers to how the vaccine performs in the wild

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vaccine efficacy is the

A

percentage of reduction in disease incidence in a vaccinated group compared to an unvaccinated group under optimal conditions (in clinical trials).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vaccine effectiveness is

A

the ability of a vaccine to prevent outcomes of interest in the “real
world”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

first antiviral discovered in the 50’s/60’s

A

amantadine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is drug resistance more frequent among RNA or DNA viruses?

A

Drug resistance is more frequent in RNA viruses because of their higher rate of mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

phage

A

or bacteriophage

is a Virus that infects bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

viroid

A

an infectious entity affecting plants, smaller than a virus and consisting only of RNA nucleic acid without a protein coat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is satellite RNA

A

Satellite RNAs and satellite viruses are extraviral components that can affect either the pathogenicity, the accumulation, or both of their associated viruses while themselves being dependent on the associated viruses as helper viruses for their infection.

Viral satellite RNAs (satRNAs) are small subviral RNAs and depend on the helper virus for replication and spread.

18
Q

virophage

A

Virophages are small, double-stranded DNA viral phages that require the co-infection of another virus. The co-infecting viruses are typically giant viruses. Virophages rely on the viral replication factory of the co-infecting giant virus for their own replication.

19
Q

prion

A

Proteinaceous infectious particles

The term “prions” refers to abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular proteins called prion proteins that are found most abundantly in the brain.

20
Q

What are the three different types of spongiform encephalopathies

A

Infectious, genetic and sporadic/spontaneous.

21
Q

Scrapie

A

a TSE affecting sheep (sometimes goats)

22
Q

CWD

A

chronic wasting disease, a TSE of cervids (deer)

Transmission: animal-to- animal and vi environment

23
Q

Four main drivers of virus evolution:

A
  1. Large numbers of progeny
  2. Large numbers of mutants
  3. Quasi-species effects
  4. Selection
24
Q

What are Quasi-species effects

A

quasispecies are dynamic distributions of non-identical but closely-related mutant and recombinant viral genomes. They are subjected to a continuous process of genetic variation, competition and selection, and act as a unit of selection.

25
Q

viral genomic recombination is

A

Recombination is when parts of different viral genomes mix or trade places during transcription.

26
Q

viral genomic reassortment is

A

viral genome segments can get “mixed” up if two virions with slightly different segments infect a cell at the same time.

Reassortment only happens in viruses with segmented genomes.

Reassortment is loads more frequent than recombination and is why influenza mutates the way it does, causing new pandemics regularly.

27
Q

Error threshold in viral mutation

A

the level of mutations that are still beneficial

If exceeded: loss of viral infectivity

If too below threshold: cannot produce enough mutations to survive selection

◦ RNA viruses evolve close to their error threshold
◦ DNA viruses evolve far below their error threshold.

28
Q

Which viruses evolve close to their error threshold?

A

RNA viruses evolve close to their error threshold

29
Q

Which viruses evolve far below their error threshold?

A

DNA viruses evolve far below their error threshold.

30
Q

Muller’s ratchet

A

small, asexual populations accumulate deleterious mutations

The theory of Muller’ Ratchet predicts that small asexual populations are doomed to accumulate ever-increasing deleterious mutation loads as a consequence of the magnified power of genetic drift and mutation that accompanies small population size.

31
Q

Genetic bottlenecks

A

A genetic bottleneck occurs when a population is greatly reduced in size, limiting the genetic diversity of the species.

Recombination and reassortment help to overcome the reduced genetic diversity caused by a genetic bottleneck.

32
Q

Antigenic shift refers to

A

genetic diversity arising after recombination or reassortment.

33
Q

Antigenic drift refers to

A

genetic diversity arising from copying-errors and immune selection.
May occur each time a genome replicates and includes accumulation of mutations over time.

34
Q

Emerging virus

A

newly discovered virus with increasing incidence

35
Q

Re-emerging virus

A

virus that has existed previously but is rapidly increasing in incidence or geographic range

36
Q

viral spillover

A

transmission of the virus into novel host population

37
Q

viral Spillback

A

transmission of the virus back to maintenance host

38
Q

Steps of emerging viral infections

A
  1. Encounter
  2. Establishment and dissemination
39
Q

A stable host-virus relationship maintains

A

the virus in the appropriate ecosystem.
E.g. herpes virus.

40
Q

An evolving host-virus relationship involves

A

passage of the virus to a naïve population.

41
Q

A dead-end host-virus relationship involves

A

one way passage to a different species. This is very common but those that produce sustainable transmission are rare.